Close Menu

NEW YORK (GenomeWeb) – As it continues to refine a novel enzymatic DNA synthesis technology for the production of long, high-fidelity DNA sequences, startup Molecular Assemblies is getting ready for a $2.5 million Series A financing round it expects will carry it to its first industry partnership.      

Founded by CEO Curt Becker and CSO William Efcavitch, two of Applied Biosystems' earliest team members, Molecular Assemblies is built around a technology dubbed EcoDNA, which the company claims holds significant advantages over classical chemical DNA synthesis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.